Mounjaro
Mounjaro is tirzepatide approved for type 2 diabetes. Like Ozempic, it's often prescribed off-label for weight loss. It contains the same active ingredient as Zepbound.
Brand-Name Cost
$1,000-1,100/month
Compounded Cost
$199-349/month
Type
GLP-1/GIP Agonist
How Mounjaro Works
Mounjaro activates both GIP and GLP-1 receptors, improving blood sugar control through multiple mechanisms including enhanced insulin secretion, reduced glucagon, and slowed gastric emptying.
Effectiveness
While approved for diabetes, Mounjaro users see significant weight loss—often 15-20% of body weight. This led to the development of Zepbound for obesity treatment.
Dosing
Weekly injection starting at 2.5mg, with increases every 4 weeks to 5mg, 7.5mg, 10mg, 12.5mg, or 15mg based on response.
FDA-Approved Uses
- Type 2 diabetes management
Get GLP-1 Updates
Weekly pricing updates, FDA news, and new provider reviews delivered to your inbox.